NEW Program! Patient Partners Leadership Training. Apply Now. Very Limited Enrolment. NEW Start date is October 2, 2020!
CORD’s Submission to PMPRB on the Revised Draft Guidelines & CORD Responses to Consultation Questions for the Proposed Alignment of CADTH Drug Reimbursement Review Processes. CORD CADTH Consultation Feedback--Aligned Process
Sign the Petition: Help Kaysen access Zolgensma a life changing gene therapy for treatment of SMA before his 2nd birthday. An open letter to Canada's provincial minister of health for access to Zolgensma.
COVID-19 Impact on Rare Disease Patients: Letter to Minsters of Health & Responses from Ministers of Health. CORD's Summary Report: Applying Lessons from COVID-19 to Better Healthcare for Rare Diseases
Surveys and Clinical Trials Recruitment- Resources & Links
Corporate Responses re: Impact of COVID-19 Pandemic on Rare Disease Patients in Canada
CORD COVID-19 Patient Member Survey: Help us better understand how COVID-19 is affecting you and your patient community
A Rare Disease Perspective During COVID-19. Self-Isolation and Social Distancing: A Way of Life for Some
Alberta delays Biosimilars forced switching until January 2021 because of COVID-19. Never would be better but at least takes stress off patients and clinicians during this really challenging time.
JOIN Patients, Families and Supporters At Parliament Hill March 10th at 12:00 pm
CORD’s Response to Patented Medicine Prices Review Board (PMPRB)
Canadian Lives Depend on New Medicines. Join the “Fight for Our Lives”